about
Androgen receptor footprint on the way to prostate cancer progressionInteraction between Chronic Inflammation and Oral HPV Infection in the Etiology of Head and Neck CancersSiltuximab (CNTO 328): a promising option for human malignanciesMechanisms of action of isothiocyanates in cancer chemoprevention: an updateSTAT3 activation in monocytes accelerates liver cancer progression.Interleukin-driven insulin-like growth factor promotes prostatic inflammatory hyperplasiaProtein biomarkers of ovarian cancer: the forest and the treesThe role of cytokines in breast cancer development and progressionAndrogen receptor signaling in prostate cancer development and progression.Elevated levels of circulating IL-7 and IL-15 in patients with early stage prostate cancer.Increased Levels of NF-kB-Dependent Markers in Cancer-Associated Deep Venous Thrombosis.Targeting the interleukin-6/Jak/stat pathway in human malignanciesFibulin-3 is a novel TGF-β pathway inhibitor in the breast cancer microenvironment.Effects of cancer therapy on hippocampus-related function.Immunomodulatory effects of total intravenous and balanced inhalation anesthesia in patients with bladder cancer undergoing elective radical cystectomy: preliminary results.Characterization of M1/M2 Tumour-Associated Macrophages (TAMs) and Th1/Th2 Cytokine Profiles in Patients with NSCLCMechanisms by which interleukin-6 attenuates cell invasion and tumorigenesis in human bladder carcinoma cells.IGF1R as a Key Target in High Risk, Metastatic Medulloblastoma.IL6 sensitizes prostate cancer to the antiproliferative effect of IFNα2 through IRF9.SOCS2 correlates with malignancy and exerts growth-promoting effects in prostate cancer.Detectability and reproducibility of plasma levels of chemokines and soluble receptors.IL-6/IL-6R as a potential key signaling pathway in prostate cancer development.The immunosuppressive cytokine interleukin-4 increases the clonogenic potential of prostate stem-like cells by activation of STAT6 signalling.STAT3-mediated SMAD3 activation underlies Oncostatin M-induced Senescence.Diacerein-mediated inhibition of IL-6/IL-6R signaling induces apoptotic effects on breast cancer.Secreted meningeal chemokines, but not VEGFA, modulate the migratory properties of medulloblastoma cells.Transcriptomic alterations in human prostate cancer cell LNCaP tumor xenograft modulated by dietary phenethyl isothiocyanate.The interleukin 6 receptor is a direct transcriptional target of E2F3 in prostate tumor derived cells.Immature myeloid cells and tolerogenic cytokine profile in lung adenocarcinoma metastatic lymph nodes assessed by endobronchial ultrasound.Interleukin-4 induces a CD44high /CD49bhigh PC3 subpopulation with tumor-initiating characteristics.Nanocarrier based approaches for targeting breast cancer stem cells.Expression of Indoleamine 2,3-Dioxygenase Induced by IFN-γ and TNF-α as Potential Biomarker of Prostate Cancer Progression.
P2860
Q26825402-02FE1F76-67F3-44C0-8864-B2FD19AC4E6EQ27495979-0B97BA50-0F4E-464F-B215-672726517C0AQ28082572-399CF339-AB6E-47C8-B236-395B65C13A92Q28248643-C0518C4B-A58C-4232-8F09-65A1D928CD23Q34089708-374F880F-8D01-4F7C-890E-E9265ACC8852Q34573875-1F8F3BE7-EAD1-4BB4-A938-E67CF6BF7F16Q34634143-7697E257-67E9-488E-85A8-32DD359CDC88Q34920381-CDE7C2DB-7F51-4DA3-8754-F30FB27923DDQ35183663-570C863F-3DD8-4290-AAF9-CA633618B339Q35318562-EB8F5F79-B6BE-4415-AFC5-77E920DEE60AQ35699340-2B27EF7D-1812-47EE-83EA-9DF03B1C55A7Q35925127-DAA7A1DC-4C57-4E0B-9848-D57BA9B2D486Q36108833-1A02FD54-573B-455F-862D-C565D22D0DC0Q36321742-22DDEA4A-4F82-43FA-9C83-07FB62287206Q36624367-85C4A455-3E2C-4C50-AF70-2D560A437E97Q36828624-37352423-DC7F-42B2-8255-DD35819425EEQ36898645-095530D8-9B86-49A7-B4E4-4BCB0D4B4F05Q36965081-5EE5FBB8-75E5-4EE8-8EA6-D3DFCB06FEEFQ37120262-58867770-F1DB-4AB1-9E6C-163464DE0C10Q37533348-8FD72426-65A9-4F72-8F42-CACC8184BEBFQ37536250-1B2C19CD-89CA-4CBA-B815-9DEE4D1D9771Q37968599-2D815A63-D592-430F-8E73-373AA8CEAE92Q38758652-71456344-8610-4A4C-B3F2-12D51AC7277DQ38790057-BF3403D2-D51A-4ACD-9BB7-90811A90E29DQ38815951-20D07EB8-29AA-499B-B04D-D842B1E32F7FQ38984930-A4299AD5-1942-4BB1-8B70-50F3B777F84FQ39401093-C254479E-0CED-49D2-B0A2-09120FFB7EE4Q39491165-1B25DBE4-44EC-4F45-8C8B-CEE3C82C3CE5Q41491985-D8901856-89F3-4082-813E-B535BF23C96CQ47253494-90AEEAEA-D8D9-4876-9DE2-EEDAD62BDF5EQ48209273-5042BAAD-E875-4CF6-B30A-C94EC3EA7496Q55253502-5993FF06-5AC8-4EB8-8B8A-9761AAAB469E
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 15 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Cytokine disbalance in common human cancers.
@en
Cytokine disbalance in common human cancers.
@nl
type
label
Cytokine disbalance in common human cancers.
@en
Cytokine disbalance in common human cancers.
@nl
prefLabel
Cytokine disbalance in common human cancers.
@en
Cytokine disbalance in common human cancers.
@nl
P1476
Cytokine disbalance in common human cancers.
@en
P2093
Zoran Culig
P304
P356
10.1016/J.BBAMCR.2010.12.010
P407
P577
2010-12-15T00:00:00Z